MIRA INFORM REPORT

 

 

Report Date :           

22.08.2011

 

IDENTIFICATION DETAILS

 

Name :

CAPSUGEL JAPAN INC

 

 

Registered Office :

4-3-36 Minamihashimoto Chuoku Sagamihara City Kanagawa-Pref 229-1133

 

 

Country :

Japan

 

 

Financials (as on) :

30.11.2010

 

 

Date of Incorporation :

December 2001

 

 

Com. Reg. No.:

(Kanagawa-Chuoku) 046108

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Manufacturer of pharmaceutical capsules, capsule filling machines

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

Yen 158.8 Million

Status :

Satisfactory

Payment Behaviour :

Usually Correct 

Litigation :

----

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2011

 

Country Name

Previous Rating

                   (31.12.2010)                  

Current Rating

(31.03.2011)

Japan

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Company name

 

 Bottom of Form

CAPSUGEL JAPAN INC

 

 

REGD NAME

 

Capsugel Japan KK

 

 

MAIN OFFICE

 

4-3-36 Minamihashimoto Chuoku Sagamihara City Kanagawa-Pref 229-1133 , JAPAN

                        Tel: 042-700-6700     Fax: 042-771-7397

                       

URL:                             http://www.capsugel-jp.com

E-Mail address:             marketingCJ@pfizer.com

 

ACTIVITIES  

 

Mfg of pharmaceutical capsules, capsule filling machines

 

 

BRANCHES

 

Nil

 

 

FACTORY

 

At the caption address

 

 

OFFICERS

 

ROBERT WHITELAW, PRES                 K Dreesen, ch

Hirokane Kyoyama, v pres                      Hiroshi Toda, v pres

 

Yen Amount:     In million Yen, unless otherwise stated

SUMMARY

 

FINANCES        FAIR                             A/SALES          Yen 6,700 M

PAYMENTS      REGULAR                     CAPITAL           Yen 310 M

TREND SLOW                          WORTH            Yen 3,527 M

STARTED         2001                             EMPLOYES      150

                                   

 

COMMENT    

 

MFR OF CAPSULES FOR PHARMACEUTICAL & HEALTH FOODS INDUSTRIES, WHOLLY OWNED BY CSUGEL JAPAN HOLDINGS INC. FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY  BUSINESS ENGAGEMENTS.

 

MAX CREDIT LIMIT: YEN 158.8 MILLION, 30 DAYS NORMAL TERMS.  .

 

 

HIGHLIGHTS

           

The subject company was established as Japan Warner Lambert KK at the caption

address for mfg capsules and capsule filling machines for the pharmaceutical industries.  After merger with a sister company and reorganization, the firm was renamed as captioned and joined Pfizer Inc group.  In Apr 2011, the firm was transferred to Capsugel Japan Holdings Inc from Pfizer inc group, and the firm became a wholly owned subsidiary of the new holding company.

 

 

FINANCIAL INFORMATION

 

Financials are only partially disclosed and in rounded-off numbers.  The firm says financials are consolidated by the parent, Capsugel Japan Holdings Inc.

 

The sales volume for Nov/2010 fiscal term said amounted to Yen 6,700 million, a 3% up from Yen 6,500 million in the previous term.  Capsule filling machines sold well, the firm says.  The net profit is believed posted at Yen 530 million, compared with Yen 540 million a year ago.  The profits were estimated figures only as not precisely disclosed.

 

For the current term ending Nov 2011 the net profit is projected at Yen 560 million, on a 4% rise in turnover, to Yen 7,000 million, to Yen 7,000 million.  The firm does not disclose sales targets, etc and this is again only estimated by us, based on the conversation with the treasurer.

 

The financial situation is considered maintained FAIR and good for ORDINARY business engagements.  Max credit limit is estimated at Yen 158.8 million, on 30 days normal terms.

 

 

REGISTRATION

 

Date Registered:  Dec 2001

Regd No.:           (Kanagawa-Chuoku) 046108

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         6,200 shares

Issued:              6,200 shares

Sum:                   Yen 310 million

Major shareholders (%): Capsugel Japan Holdings Inc*(100)

*.. Holding company at the caption address

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

 

Activities: Manufactures capsules, including hard gelatin, soft-gel, non-animal & fish gelatin capsules, capsule filling machines, liquid filling and sealing equipment, clinical   trial & manual filling machines, replacement parts, others (--100%).

           

Clients: Pharmaceutical mfrs, dietary supplement industry, wholesalers, drug stores, other 

            No. of accounts: 800

            Domestic areas of activities: Nationwide

 

Suppliers: [Mfrs, wholesalers] Nitta Gelatin, Hayashibara Shoji, other. 

Also supplied from L D Davis Ind Inc, USA, other.

 

Payment record: Regular

 

Location: Business area in Sagamihara City, Kanagawa-Pref.  Office premises at the caption address are owned and maintained satisfactorily.

 

Bank References:

·         Mizuho Bank (Hashimoto)

·         MUFG (Shinjuku-Fukutoshin)

Relations: Satisfactory

 

 

FINANCES

(In Million Yen)

 

Terms Ending:

　

30/11/2011

30/11/2010

30/11/2009

30/11/2008

Annual Sales

　

7,000

6,700

6,500

6,300

Recur. Profit

　

　

　

　

　

Net Profit

　

560

530

540

530

Total Assets

　

　

9,070

N/A

N/A

Net Worth

　

　

3,527

3,156

2,778

Capital, Paid-Up

　

　

310

310

310

Div.P.Share(¥)

　

　

0.00

0.00

0.00

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

4.48

3.08

3.17

-3.08

    Current Ratio

 

 

..

..

..

    N.Worth Ratio

 

38.89

..

..

    N.Profit/Sales

8.00

7.91

8.31

8.41

 

Note: Financials are only partially disclosed.  Sales/profits were not precisely disclosed and all figures are estimated.

Forecast (or estimated) figures for the 30/11/2011 fiscal term.

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.45.61

UK Pound

1

Rs.75.32

Euro

1

Rs.65.68

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.